血液透析在尿毒症合并冠心病患者治疗中的应用
|
摘要
目的探讨血液透析在尿毒症合并冠心病患者治疗中的应用效果。方法随机选取2016年2月～2018年2月收治的尿毒症合并冠心病患者共计40例,患者均实施血液透析治疗,对比治疗前后患者的因子水平和生化指标以及治疗前、治疗后并发症发生情况。结果治疗后患者在CRP、SCr、Alb等因子水平指标均优于治疗前,差异有统计学意义(P <0.05);治疗后患者在Hb、BUN、K异有统计学意义(P <0.05);治疗后患者并发症发生率为5.00%,治疗前患者并发症发生率为50.00%,治疗后并发症发生率明显低于治疗前,差异有统计学意义(P <0.05)。结论血液透析治疗在尿毒症合并冠心病患者中的治疗效果较好,可在临床实践中予以广泛推广和应用。
Objective To discuss the application effect of hemodialysis in the treatment of uremia combined with coronary heart disease. Methods 40 patients with uremia combined with coronary heart disease who admitted to our hospital from February 2016 to February 2018 underwent hemodialysis treatment.Factors,biochemical indexes and complications before and after treatment were compared. Results CRP,SCr,Alb and other factors after treatment were all better than those before treatment,and the difference between the groups was statistically significant(P < 0.05).Biochemical indexes such as Hb,BUN,K+, etc.The patients after treatment were better than those before treatment,and the difference between the groups was significant(P < 0.05).The incidences of complications after and before the treatment were 5.00%and 50.00%,respectively, and significantly lower than that before treatment(P < 0.05).Conclusion Hemodialysis is effective in treating patients with uremia complicated with coronary heart disease,which can be widely used in clinical practice.
Objective To discuss the application effect of hemodialysis in the treatment of uremia combined with coronary heart disease. Methods 40 patients with uremia combined with coronary heart disease who admitted to our hospital from February 2016 to February 2018 underwent hemodialysis treatment.Factors,biochemical indexes and complications before and after treatment were compared. Results CRP,SCr,Alb and other factors after treatment were all better than those before treatment,and the difference between the groups was statistically significant(P < 0.05).Biochemical indexes such as Hb,BUN,K+, etc.The patients after treatment were better than those before treatment,and the difference between the groups was significant(P < 0.05).The incidences of complications after and before the treatment were 5.00%and 50.00%,respectively, and significantly lower than that before treatment(P < 0.05).Conclusion Hemodialysis is effective in treating patients with uremia complicated with coronary heart disease,which can be widely used in clinical practice.
引文
[1]智霞,李慧君,王景梅,等.血液灌流联合血液透析治疗尿毒症合并银屑病的临床观察[J].中国血液净化,2015,14(10):639.
[2]李春艳.探析合理运用硝苯地平治疗尿毒症血液透析合并高血压患者的有效性[J].中国卫生标准管理,2015,6(6):241-242.
[3]洪康迪.低分子肝素在尿毒症合并脑出血患者血液透析中的应用[J].中国处方药,2017,15(2):109-110.
[4]郑伟平.腹膜透析与血液透析在尿毒症合并糖尿病患者治疗中的应用及价值对比研究[J].实用中西医结合临床,2016,16(5):18-19.
[5]谭广霞.综合护理在尿毒症合并心力衰竭血液透析治疗中的效果观察[J].基层医学论坛,2016,20(15):2144-2145.
[6]王超民,薛增芬.左卡尼汀与血液透析联合应用对尿毒症患者周围神经病变的疗效[J].中国卫生标准管理,2015,6(26):79-81.
[7]方倩瑜,匡彬.高通量血液透析治疗尿毒症合并高血压临床研究[J].吉林医学,2014,35(6):1150.
[8]陈秋莲.老年尿毒症合并高血压患者血液透析虑过治疗的观察及护理[J].中外医疗,2014,33(3):158-159.
[9]卢旭明.无创正压通气在尿毒症合并急性左心衰竭患者血液透析中的应用体会[J].医学理论与实践,2012,25(12):1408-1409.
[10]杨成林,郑忠爱,肖斌,等.血液透析对难治性心力衰竭合并尿毒症患者血液生化指标和心功能的影响[J].医学综述,2016,22(7):1412-1414.
[11]李霞,贾卫国.无肝素连续性床旁血液净化治疗尿毒症合并脑出血的疗效观察[J].疾病监测与控制,2014,8(9):579-580.
[12]段瑞,郑席志,张洁婷.短程每日血液透析治疗早期尿毒症合并心力衰竭的临床观察[J].全科护理,2016,14(1):34-35.
[13]孙丽丽.血液透析联合灌注治疗糖尿病合并尿毒症患者的护理效果观察[J].糖尿病新世界, 2015,35(15):157-158.
[14]马媛,史佳佳.评价综合护理对尿毒症患者血液透析期间合并心衰的效果[J].中西医结合心血管病电子杂志,2015,3(30):180-181.
[15]纪镇华,邓雪梅,董艳,等.不同频率血液灌流联合血液透析治疗尿毒症合并心血管病的疗效对比分析[J].中国医疗器械信息,2017,23(6):52-53.
[2]李春艳.探析合理运用硝苯地平治疗尿毒症血液透析合并高血压患者的有效性[J].中国卫生标准管理,2015,6(6):241-242.
[3]洪康迪.低分子肝素在尿毒症合并脑出血患者血液透析中的应用[J].中国处方药,2017,15(2):109-110.
[4]郑伟平.腹膜透析与血液透析在尿毒症合并糖尿病患者治疗中的应用及价值对比研究[J].实用中西医结合临床,2016,16(5):18-19.
[5]谭广霞.综合护理在尿毒症合并心力衰竭血液透析治疗中的效果观察[J].基层医学论坛,2016,20(15):2144-2145.
[6]王超民,薛增芬.左卡尼汀与血液透析联合应用对尿毒症患者周围神经病变的疗效[J].中国卫生标准管理,2015,6(26):79-81.
[7]方倩瑜,匡彬.高通量血液透析治疗尿毒症合并高血压临床研究[J].吉林医学,2014,35(6):1150.
[8]陈秋莲.老年尿毒症合并高血压患者血液透析虑过治疗的观察及护理[J].中外医疗,2014,33(3):158-159.
[9]卢旭明.无创正压通气在尿毒症合并急性左心衰竭患者血液透析中的应用体会[J].医学理论与实践,2012,25(12):1408-1409.
[10]杨成林,郑忠爱,肖斌,等.血液透析对难治性心力衰竭合并尿毒症患者血液生化指标和心功能的影响[J].医学综述,2016,22(7):1412-1414.
[11]李霞,贾卫国.无肝素连续性床旁血液净化治疗尿毒症合并脑出血的疗效观察[J].疾病监测与控制,2014,8(9):579-580.
[12]段瑞,郑席志,张洁婷.短程每日血液透析治疗早期尿毒症合并心力衰竭的临床观察[J].全科护理,2016,14(1):34-35.
[13]孙丽丽.血液透析联合灌注治疗糖尿病合并尿毒症患者的护理效果观察[J].糖尿病新世界, 2015,35(15):157-158.
[14]马媛,史佳佳.评价综合护理对尿毒症患者血液透析期间合并心衰的效果[J].中西医结合心血管病电子杂志,2015,3(30):180-181.
[15]纪镇华,邓雪梅,董艳,等.不同频率血液灌流联合血液透析治疗尿毒症合并心血管病的疗效对比分析[J].中国医疗器械信息,2017,23(6):52-53.